{
    "clinical_study": {
        "@rank": "158262", 
        "acronym": "TRANEXTUM", 
        "arm_group": [
            {
                "arm_group_label": "Tranexamic acid", 
                "arm_group_type": "Experimental", 
                "description": "Tranexamic acid, 1g intra-articular before closing the surgery wound"
            }, 
            {
                "arm_group_label": "Fibrin glue", 
                "arm_group_type": "Experimental", 
                "description": "One intra-articular dose of fibrin glue (Evicel 5mL) before closing the wound surgery"
            }, 
            {
                "arm_group_label": "Usual hemostasia", 
                "arm_group_type": "Active Comparator", 
                "description": "Electrocauterization"
            }
        ], 
        "brief_summary": {
            "textblock": "Massive bone tumour resection is often associated with important postoperative bleeding.\n      This may determine systemic (anaemia), as well as local complications (wound healing,\n      seroma, haematoma).\n\n      The objective of this study is to determine whether the use of topical tranexamic acid or\n      topical Evicel\u00ae will reduce the perioperative bleeding comparing it with  usual haemostasis."
        }, 
        "brief_title": "Postoperative Bleeding Prevention in Massive Bone Tumour Resection: a Multicentric, Randomized, Parallel, Controlled Trial", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Blood Loss", 
            "Bone Tumour"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bone Neoplasms", 
                "Hemorrhage", 
                "Postoperative Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years and older\n\n          -  Osseous tumor (primary or metastatic, benign or malignant) located in extremities,\n             shoulder girdle or pelvis.\n\n          -  Massive or bloc tumour resection.\n\n          -  Patient's consent to participate\n\n        Exclusion Criteria:\n\n          -  Known allergy to ATX\n\n          -  Allergy or known hypersensitivity to bovine proteins (aprotinin)\n\n          -  Liposarcomas low grade\n\n          -  History of thromboembolic disease or prothrombotic conditions:\n\n               -  cerebral vascular accident\n\n               -  ischemic heart disease\n\n               -  deep and / or superficial vein thrombosis\n\n               -  pulmonary embolism\n\n               -  peripheral arterial vasculopathy\n\n               -  thrombogenic arrhythmias (eg: ACxFA)\n\n               -  patients with cardiovascular stents\n\n               -  prothrombotic alterations in coagulation\n\n               -  Treatment with contraceptive drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "135", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 27, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02153593", 
            "org_study_id": "IIBSP-EVI-2011-138", 
            "secondary_id": [
                "EC11-340", 
                "2011-006276-40"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Tranexamic acid", 
                "description": "1g intra-articular before closing the wound surgery", 
                "intervention_name": "Tranexamic Acid", 
                "intervention_type": "Drug", 
                "other_name": "Amchafibrin"
            }, 
            {
                "arm_group_label": "Fibrin glue", 
                "description": "5mL intra-articular before closing the wound surgery", 
                "intervention_name": "Fibrin glue", 
                "intervention_type": "Drug", 
                "other_name": "Evicel"
            }, 
            {
                "arm_group_label": [
                    "Tranexamic acid", 
                    "Fibrin glue", 
                    "Usual hemostasia"
                ], 
                "description": "Coagulation blood from vessels by means of a electrocautery", 
                "intervention_name": "Electrocauterization", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fibrin Tissue Adhesive", 
                "Tranexamic Acid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Clinical trial", 
            "Randomized", 
            "Fibrin glue", 
            "Tranexamic acid", 
            "Blood loss"
        ], 
        "lastchanged_date": "June 2, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "L Areizaga, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barakaldo,", 
                        "country": "Spain", 
                        "state": "Vizcaya", 
                        "zip": "48903"
                    }, 
                    "name": "Hospital Universitario de Cruces"
                }, 
                "investigator": {
                    "last_name": "L Areizaga, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "R Alacal\u00e0, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Alicante", 
                        "country": "Spain", 
                        "zip": "03550"
                    }, 
                    "name": "Hospital Universitario de San Juan de Alicante"
                }, 
                "investigator": {
                    "last_name": "R Alcal\u00e0, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "A Peir\u00f3, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08025"
                    }, 
                    "name": "Hospital de la Santa Creu i Sant Pau"
                }, 
                "investigator": {
                    "last_name": "A Peir\u00f3, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "3", 
        "official_title": "Postoperative Bleeding Prevention in Massive Bone Tumour Resection: a Multicentric, Randomized, Parallel, Controlled Trial to Assess the Efficacy of Tranexamic Acid Versus Evicel\u00ae and Usual Haemostasis", 
        "overall_contact": {
            "email": "mmartinezz@santpau.cat", 
            "last_name": "MJ Martinez-Zapata, MD, PhD", 
            "phone": "34 93 553 78 08"
        }, 
        "overall_official": {
            "affiliation": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
            "last_name": "Ana Peir\u00f3, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The blood loss will be collected by the drainage system and quantified in mL.", 
            "measure": "Total blood loss (mL) in the postoperative period", 
            "safety_issue": "No", 
            "time_frame": "The first postoperative 48h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02153593"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Proportion of patients requiring blood transfusion", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative 2 weeks"
            }, 
            {
                "measure": "Units of blood transfused", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative 2 weeks"
            }, 
            {
                "measure": "Proportion of patients with wound infection", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Proportion of patients with wound dehiscence", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Proportion of patients with reoperation for wound complications", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Deep venous thrombosis", 
                "safety_issue": "No", 
                "time_frame": "The first postoperative 2 weeks"
            }, 
            {
                "measure": "Proportion of patients with seroma", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Postoperative pain related with the surgery", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative week"
            }, 
            {
                "measure": "Tumoral local relapse rate", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Tumoral systemic dissemination rate", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Mortality", 
                "safety_issue": "No", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Proportion of patients in which chemotherapy is delayed for wound complications", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Proportion of patients in which radiotherapy is delayed for wound complications.", 
                "safety_issue": "Yes", 
                "time_frame": "The first postoperative month"
            }, 
            {
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "The first postoperative 2 weeks"
            }
        ], 
        "source": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fundaci\u00f3 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}